Lung transplant complications: Difference between revisions

(Text replacement - "==Diagnosis==" to "==Evaluation==")
No edit summary
Line 1: Line 1:
==Background==
==Background==
{{Transplant emergency types}}
*Can transplant single lung, bilateral lungs, or heart-lungs
*Indications: [[cystic fibrosis]], [[COPD]], idiopathic [[pulmonary fibrosis]] > alpha-1 antitrypsin deficiency, primary pulmonary hypertension, bronchiectasis, [[sarcoidosis]]
*Lung is denervated
**regulation of breathing is not lost, as it is through chest wall efferents
**cough response lost below anastomosis
**should have normal ABG (unless patient reliant on hypoxic respiratory drive), exercise response, and bronchomotor tone


{{Immunosuppressant medication complications}}
{{Immunosuppressant medication complications}}


==Clinical Features==
==Clinical Features/Differential Diagnosis==
*Signs/symptoms of infection
*[[Fever]], [[cough]], worsening [[SOB]], hypoxia, tachypnea


==Differential Diagnosis==
==Differential Diagnosis==
===Infection===
*Bronchitis, [[Pneumonia]] (common)
**usually bacterial early in course
**MRSA and [[pseudomonas]] common
**Fungi, protazoa, CMV more common >6 weeks post-op
*Extra-pulmonary infections (may be severe or opportunistic due to immunosuppression)
===Medication adverse effects===
*Prednisone
**Hyperglycemia, psychiatric symptoms, poor wound healing, edema, hypertension
*Tacrolimus, cyclosporine
**Neurotoxicity, tremor, hyperkalemia, nephrotoxicity, hypertension, hyperglycemia, gout
*Mycophenolate
**Cytopenias, GI distress
*Azathioprine
**Cytopenias, pancreatitis, hepatitis
===Airway complications===
*Anastomotic bronchial necrosis, dehiscence, or stenosis
**bronchial vasculature is disrupted during procedure, ergo:
***donor bronchus reliant on retrograde pulmonary circulation for perfusion
***anastomoses vulnerable to ischemia
**mild cases may be asymptomatic
**may lead to worsening respiratory symptoms, [[pneumothorax]], [[pneumomediastinum]], focal infections/abscess
*Occlusive granulation tissue
**Asymptomatic, or worsening cough, wheezing, post-obstructive pneumonia
*bronchial/tracheal stenosis, tracheobronchomalacia
**cough, dyspnea, difficulty clearing respiratory secretions, recurrent infections, wheezing, stridor
*bronchopleural, bronchomediastinal, or bronchovascular fisulae
**can cause [[pneumothorax]], [[hypotension]], [[mediastinitis]], [[pneumomediastinum]], [[respiratory distress]]
*Pulmonary vasculature problems
**Pulmonary artery stricture--> hypoxia
**Pulmonary venous anastomoses: vulnerable to kinking, [[pulmonary embolism]], and thromboses--> [[pulmonary edema]]
*Rejection
**Acute/cellular rejection: clinically silent or nonspecific respiratory symptoms
**Chronic rejection (bronchiolitis obliterans): leads to airflow limitation


==Evaluation==
==Evaluation==

Revision as of 23:18, 28 September 2016

Background

  • Can transplant single lung, bilateral lungs, or heart-lungs
  • Indications: cystic fibrosis, COPD, idiopathic pulmonary fibrosis > alpha-1 antitrypsin deficiency, primary pulmonary hypertension, bronchiectasis, sarcoidosis
  • Lung is denervated
    • regulation of breathing is not lost, as it is through chest wall efferents
    • cough response lost below anastomosis
    • should have normal ABG (unless patient reliant on hypoxic respiratory drive), exercise response, and bronchomotor tone

Immunosuppressant Medications

Clinical Features/Differential Diagnosis

  • Signs/symptoms of infection
  • Fever, cough, worsening SOB, hypoxia, tachypnea

Differential Diagnosis

Infection

  • Bronchitis, Pneumonia (common)
    • usually bacterial early in course
    • MRSA and pseudomonas common
    • Fungi, protazoa, CMV more common >6 weeks post-op
  • Extra-pulmonary infections (may be severe or opportunistic due to immunosuppression)

Medication adverse effects

  • Prednisone
    • Hyperglycemia, psychiatric symptoms, poor wound healing, edema, hypertension
  • Tacrolimus, cyclosporine
    • Neurotoxicity, tremor, hyperkalemia, nephrotoxicity, hypertension, hyperglycemia, gout
  • Mycophenolate
    • Cytopenias, GI distress
  • Azathioprine
    • Cytopenias, pancreatitis, hepatitis

Airway complications

  • Anastomotic bronchial necrosis, dehiscence, or stenosis
    • bronchial vasculature is disrupted during procedure, ergo:
      • donor bronchus reliant on retrograde pulmonary circulation for perfusion
      • anastomoses vulnerable to ischemia
    • mild cases may be asymptomatic
    • may lead to worsening respiratory symptoms, pneumothorax, pneumomediastinum, focal infections/abscess
  • Occlusive granulation tissue
    • Asymptomatic, or worsening cough, wheezing, post-obstructive pneumonia
  • bronchial/tracheal stenosis, tracheobronchomalacia
    • cough, dyspnea, difficulty clearing respiratory secretions, recurrent infections, wheezing, stridor
  • bronchopleural, bronchomediastinal, or bronchovascular fisulae
  • Pulmonary vasculature problems
  • Rejection
    • Acute/cellular rejection: clinically silent or nonspecific respiratory symptoms
    • Chronic rejection (bronchiolitis obliterans): leads to airflow limitation

Evaluation

Management

Disposition

See Also

External Links

References